Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Translational Lung Cancer Research|March 4, 2022
Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case reportVincent Yeung, Chul Kim, Lesli A Kiedrowski, et al.
The Journal of Family Practice|December 5, 2017
Subacute loss of vision in one eye · rash on hands and feet · plaques with scaling on genitals · Dx?Abigail Nunn, Jeffrey M Sturek, Joshua E Reuss, et al.
JTO Clinical and Research Reports|April 14, 2025
Discordant Response to Nivolumab Plus Ipilimumab and Identification of BRAF V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case ReportOlivia Wilkins, Adedamola Omogbehin, Peter J Bergquist, et al.
JAMA Oncology|November 17, 2022
Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A ReviewAakash P Desai, Jacob J Adashek, Joshua E Reuss, et al.
Clinical Lung Cancer|July 7, 2023
Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsMatthew Z Guo, Aanika Balaji, Joseph C Murray, et al.
Journal for Immunotherapy of Cancer|December 30, 2016
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literatureJoshua E Reuss, Paul R Kunk, Anne M Stowman, et al.
Clinical Lung Cancer|January 16, 2025
Statin Use With Immune Checkpoint Inhibitors and Survival in Nonsmall Cell Lung CancerMichael T Marrone, Joshua E Reuss, Anna Crawford, et al.
Endocrinology|September 14, 2013
Pancreatic duct ligation after almost complete β-cell loss: exocrine regeneration but no evidence of β-cell regenerationClaudia Cavelti-Weder, Maria Shtessel, Joshua E Reuss, et al.
JTO Clinical and Research Reports|October 3, 2022
Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case ReportMolly Wilgucki, Vincent Yeung, Grace Ho, et al.
JAMIA Open|November 7, 2024
Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancerKrithika Bhuvaneshwar, Chul Kim, Kaushal Parikh, et al.
Pageof 6